SAN FRANCISCO (MarketWatch) - Eli Lilly and Co. and Amylin Pharmaceuticals Inc. on Saturday said their Byetta injection treatment was shown to lower blood glucose levels for people with Type II ...
Study over 24 weeks on patients with type 2 diabetes Says exenatide once-weekly shows superior glucose control Dec 15 (Reuters) - Amylin Pharmaceuticals Inc reported positive data from a study that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results